Agreement signedAgreed 12 Apr 2022
Halozyme Therapeutics, Inc. /
Antares Pharma, Inc.
Halozyme Therapeutics, Inc. agrees to buy Antares Pharma, Inc.
- Price
- $957m
- Stage
- Agreement signed
01 / BuyerHalozyme Therapeutics, Inc.
02 / TargetAntares Pharma, Inc.
What happened
Halozyme Therapeutics, Inc. agreed to acquire Antares Pharma, Inc. for approximately $957 million, according to a filing dated May 24, 2022.
Who is involved, and the source
Everything on this page comes from the source below.
Advisers
Target
- Financial adviser to the targetJefferiesAdviser profile
Advisers are not parties to the deal.
01
Source · Source
Halozyme Therapeutics, Inc. agrees to buy Antares Pharma, Inc.
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Announced
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly